116 related articles for article (PubMed ID: 8055650)
21. Heterogeneity of O6-alkylguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells.
Liu L; Lee K; Schupp J; Koç ON; Gerson SL
Clin Cancer Res; 1998 Feb; 4(2):475-81. PubMed ID: 9516939
[TBL] [Abstract][Full Text] [Related]
22. Enhanced repair of O6-methylguanine DNA adducts in the liver of transgenic mice expressing the ada gene.
Dumenco LL; Arce C; Norton K; Yun J; Wagner T; Gerson SL
Cancer Res; 1991 Jul; 51(13):3391-8. PubMed ID: 2054779
[TBL] [Abstract][Full Text] [Related]
23. Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues.
Gerson SL; Trey JE; Miller K; Berger NA
Carcinogenesis; 1986 May; 7(5):745-9. PubMed ID: 3698202
[TBL] [Abstract][Full Text] [Related]
24. Studies in gastric carcinogenesis. IV. O6-methylguanine and its repair in normal and atrophic biopsy specimens of human gastric mucosa. Correlation of O6-alkylguanine-DNA alkyltransferase activities in gastric mucosa and circulating lymphocytes.
Kyrtopoulos SA; Ampatzi P; Davaris P; Haritopoulos N; Golematis B
Carcinogenesis; 1990 Mar; 11(3):431-6. PubMed ID: 2311187
[TBL] [Abstract][Full Text] [Related]
25. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.
Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P
Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842
[TBL] [Abstract][Full Text] [Related]
26. The repair of the tobacco specific nitrosamine derived adduct O6-[4-Oxo-4-(3-pyridyl)butyl]guanine by O6-alkylguanine-DNA alkyltransferase variants.
Mijal RS; Thomson NM; Fleischer NL; Pauly GT; Moschel RC; Kanugula S; Fang Q; Pegg AE; Peterson LA
Chem Res Toxicol; 2004 Mar; 17(3):424-34. PubMed ID: 15025514
[TBL] [Abstract][Full Text] [Related]
27. Assay by inhibition of repair to measure O6-methylguanine in DNA.
Mironov NM; Martel-Planche G; Wild CP
Environ Mol Mutagen; 1994; 23(2):110-5. PubMed ID: 8143697
[TBL] [Abstract][Full Text] [Related]
28. O6-methylguanine and O6-methylguanine-DNA [corrected] methyltransferase activity in tissues of BDF-1 mice treated with antiparasitic drugs.
Badawi AF
Toxicol Lett; 1998 Feb; 94(3):199-208. PubMed ID: 9609323
[TBL] [Abstract][Full Text] [Related]
29. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Fiacchini M; Lauria F; Mazza P; Tura S
Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
[No Abstract] [Full Text] [Related]
31. Relevance of environmental alkylating agents to repair protein O6-alkylguanine-DNA alkyltransferase: determination of individual and collective repair capacities of O6-methylguanine.
Oesch F; Klein S
Cancer Res; 1992 Apr; 52(7):1801-3. PubMed ID: 1532345
[TBL] [Abstract][Full Text] [Related]
32. Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer.
Schilsky RL; Dolan ME; Bertucci D; Ewesuedo RB; Vogelzang NJ; Mani S; Wilson LR; Ratain MJ
Clin Cancer Res; 2000 Aug; 6(8):3025-31. PubMed ID: 10955780
[TBL] [Abstract][Full Text] [Related]
33. Pyridyloxobutyl adduct O6-[4-oxo-4-(3-pyridyl)butyl]guanine is present in 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone-treated DNA and is a substrate for O6-alkylguanine-DNA alkyltransferase.
Wang L; Spratt TE; Liu XK; Hecht SS; Pegg AE; Peterson LA
Chem Res Toxicol; 1997 May; 10(5):562-7. PubMed ID: 9168254
[TBL] [Abstract][Full Text] [Related]
34. Repair of O6-methylguanine and O4-methylthymidine in F344 rat liver following treatment with 1,2-dimethylhydrazine and O6-benzylguanine.
O'Toole SM; Pegg AE; Swenberg JA
Cancer Res; 1993 Sep; 53(17):3895-8. PubMed ID: 8358714
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
Dolan ME; Chae MY; Pegg AE; Mullen JH; Friedman HS; Moschel RC
Cancer Res; 1994 Oct; 54(19):5123-30. PubMed ID: 7923129
[TBL] [Abstract][Full Text] [Related]
37. Pyridyloxobutylation of guanine residues by 4-[(acetoxymethyl)nitrosamino]-1-(3-pyridyl)-1-butanone generates substrates of O6-alkylguanine-DNA alkyltransferase.
Liu XK; Spratt TE; Murphy SE; Peterson LA
Chem Res Toxicol; 1996 Sep; 9(6):949-53. PubMed ID: 8870981
[TBL] [Abstract][Full Text] [Related]
38. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
Swerdlow AJ; Schoemaker MJ; Allerton R; Horwich A; Barber JA; Cunningham D; Lister TA; Rohatiner AZ; Vaughan Hudson G; Williams MV; Linch DC
J Clin Oncol; 2001 Mar; 19(6):1610-8. PubMed ID: 11250989
[TBL] [Abstract][Full Text] [Related]
39. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine.
Dolan ME; Pegg AE; Dumenco LL; Moschel RC; Gerson SL
Carcinogenesis; 1991 Dec; 12(12):2305-9. PubMed ID: 1747932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
